| 1.        郗彦凤(通讯作者)Effective   Combination of Targeted Therapies with SonodynamicTreatment for Use in   Exploring Differences in Therapeutic Efficacy across Organelle Targets.    Mol.   Pharmaceutics 2024, 21, 2, 760–769 影响因子:4.5 2.        郗彦凤(通讯作者)Clinicopathological   and genomic characterization of intestinal adenosquamous carcinoma. Br J   Surg,2024,111(10)影响因子:8.7 3.        郗彦凤(通讯作者)The   splicing factor SF3B1 confers ferroptosis resistance and promotes lung    adenocarcinoma progression via upregulation of SLC7A11. Cancer Gene Ther.   2024 Oct;31(10):1498-1510. 影响因子:4.8 4.        郗彦凤(通讯作者)Exploring   the expression and clinical significance of the miR-140-3p-HOXA9 axis    in colorectal cancer.Cancer Res Clin Oncol.2023,149(13):11397-11410影响因子:2.7 5.        郗彦凤(通讯作者)CDKN2A   promoter methylation enhances self-renewal of glioblastoma stem cells   and  confers resistance to carmustine.    Mol Biol   Rep,2024,51(1):385.影响因子:2.6 6.        郗彦凤(通讯作者)Differential   expression of BCL11b and CDKN2A in CD30-positive peripheral T cell lymphoma   Retrospective study      Observational Study (2023)   102:46 1-7 7.        郗彦凤(通讯作者)结直肠癌组织中肿瘤血管正常化的研究进展.中华病理学杂志.2024,53(8): 135-139.  8.        郗彦凤(通讯作者)消皮素家族介导细胞焦亡在结直肠癌中的研究进展. 中华实验外科杂志2023.40(11):   2415-2419 9.        郗彦凤(通讯作者)非小细胞肺癌PD‑L1表达临床检测中国专家共识(2023版)中华病理学杂志.2024,53(3): 121-129. 10.   郗彦凤(通讯作者)非小细胞肺癌分子病理检测临床实践指南 11.   (2024版)中华病理学杂志.2024,53(10):   981-994. |